Purine inhibitors of human phosphatidylinositol 3-kinase delta
US11179389B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2018 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Dec 12, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.